Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Remuneration Information 2017

Feb 13, 2017

5262_rns_2017-02-13_d023f637-f063-477c-8f19-7168cde732a3.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7692W

GlaxoSmithKline PLC

13 February 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr N Hirons

b)

Position/status

SVP, Global Ethics & Compliance

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each

ISIN: GB0009252882

b)

Nature of the transaction

Following the vesting on 12 February 2017 of an award made on 24 September 2014 under the GlaxoSmithKline Deferred Investment Award Plan, Mr N Hirons will receive a cash payment of £236,799 less applicable tax withholding in respect of 14,940 notional ordinary shares.

c)

Price(s) and

volume(s)

Price(s) Volume(s)
£15.850 14,940

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2017-02-12

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDXLFFDLFBBBX